Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth

US7323481B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Sabine Bauer · Munich, DE
• Markus Meyer · Hannover, DE
• Tobias Schnitzer · Munich, DE
• Christine Schuell · Penzberg, DE
• Hans-Peter Wolff · Mannheim, DE

Key dates

• Filing date: Apr 4, 2002
• Grant date: Jan 29, 2008
• Expiry date: Apr 4, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Use of thiazolidinedione derivatives for the preparation of medicaments for inhibiting or reducing tumour growth or metastases, alone or in combination with an RXR agonist or well-known antitumour agent.